{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:23:25Z","timestamp":1789773805658,"version":"4.0.1"},"reference-count":33,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3201\/eid2310.170724","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T15:40:43Z","timestamp":1503934843000},"page":"1664-1670","source":"Crossref","is-referenced-by-count":14,"title":["Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India"],"prefix":"10.3201","volume":"23","author":[{"given":"Madhu Chhanda","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha Rajan","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Taur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma Prajwal","family":"Nalavade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa Kailash","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Shabrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahnavi","family":"Aluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish Mohanrao","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2310.170724-201709180824-R1","unstructured":"World Health Organization. Progress towards global interruption of wild poliovirus transmission, January 2011\u2013March 2012. Wkly Epidemiol Rec. 2012;87:195\u2013200."},{"key":"key-10.3201\/eid2310.170724-201709180824-R2","doi-asserted-by":"crossref","unstructured":"Sutter RW, Kew OM, Cochi S, Aylward B. Poliovirus vaccine\u2014live. In: Plotkin, SA, Orenstein, W, Offit, PA, editors. Vaccines, 6th ed. Philadelphia: Elsevier; 2012. p. 598\u2013645.","DOI":"10.1016\/B978-1-4557-0090-5.00035-5"},{"key":"key-10.3201\/eid2310.170724-201709180824-R3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/oxfordjournals.aje.a120717","article-title":"Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter.","volume":"86","author":"Benyesh-Melnick","year":"1967","journal-title":"Am J Epidemiol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R4","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/jama.1996.03530450029028","article-title":"Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.","volume":"275","author":"Chen","year":"1996","journal-title":"JAMA"},{"key":"key-10.3201\/eid2310.170724-201709180824-R5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015","volume":"35","author":"Picard","year":"2015","journal-title":"J Clin Immunol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2217\/IMT.15.74","article-title":"Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities.","volume":"7","author":"Eibl","year":"2015","journal-title":"Immunotherapy"},{"key":"key-10.3201\/eid2310.170724-201709180824-R7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2015.01.018","article-title":"Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.","volume":"33","author":"Guo","year":"2015","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2310.170724-201709180824-R8","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3201\/eid2210.151071","article-title":"Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995\u20132014.","volume":"22","author":"Shaghaghi","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2310.170724-201709180824-R9","first-page":"741","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, April 2011-June 2012.","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2310.170724-201709180824-R10","first-page":"640","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2014\u2013March 2015.","volume":"64","author":"Diop","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2310.170724-201709180824-R11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.15585\/mmwr.mm6530a3","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2015\u2013May 2016.","volume":"65","author":"Jorba","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2310.170724-201709180824-R12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication.","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R13","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1128\/CVI.00293-12","article-title":"High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.","volume":"19","author":"Driss","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R14","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.1016\/j.vaccine.2012.10.035","article-title":"Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka.","volume":"30","author":"de Silva","year":"2012","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2310.170724-201709180824-R15","doi-asserted-by":"publisher","first-page":"S368","DOI":"10.1093\/infdis\/jiu065","article-title":"Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series.","volume":"210","author":"Li","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2310.170724-201709180824-R16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10875-015-0198-5","article-title":"The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies.","volume":"35","author":"Bousfiha","year":"2015","journal-title":"J Clin Immunol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10875-012-9829-2","article-title":"Comprehensive report of primary immunodeficiency disorders from a tertiary care center in India.","volume":"33","author":"Madkaikar","year":"2013","journal-title":"J Clin Immunol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R18","unstructured":"World Health Organization. Manual for the Virological Investigation of Polio. Geneva: The Organization; 2004."},{"key":"key-10.3201\/eid2310.170724-201709180824-R19","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1128\/JVI.73.3.1941-1948.1999","article-title":"Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.","volume":"73","author":"Oberste","year":"1999","journal-title":"J Virol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R20","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1128\/JCM.00542-06","article-title":"Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens.","volume":"44","author":"Nix","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jviromet.2011.03.020","article-title":"Poliovirus serotype-specific VP1 sequencing primers.","volume":"174","author":"Kilpatrick","year":"2011","journal-title":"J Virol Methods"},{"key":"key-10.3201\/eid2310.170724-201709180824-R22","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1128\/JCM.37.5.1288-1293.1999","article-title":"Typing of human enteroviruses by partial sequencing of VP1.","volume":"37","author":"Oberste","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1086\/596052","article-title":"Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota.","volume":"199","author":"Alexander","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2310.170724-201709180824-R24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.15585\/mmwr.mm6530a3","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2015\u2013May 2016.","volume":"65","author":"Jorba","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2310.170724-201709180824-R25","first-page":"3","article-title":"Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom.","volume":"82","author":"Halsey","year":"2004","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid2310.170724-201709180824-R26","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.3201\/eid2310.170724-201709180824-R27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3201\/eid1607.091606","article-title":"Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008.","volume":"16","author":"Shahmahmoodi","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2310.170724-201709180824-R28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12879-016-1587-y","article-title":"Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.","volume":"16","author":"Foiadelli","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2310.170724-201709180824-R29","first-page":"1272","article-title":"Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses.","volume":"151","author":"Hammon","year":"1953","journal-title":"J Am Med Assoc"},{"key":"key-10.3201\/eid2310.170724-201709180824-R30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/jinf.2002.1066","article-title":"Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality.","volume":"46","author":"Halliday","year":"2003","journal-title":"J Infect"},{"key":"key-10.3201\/eid2310.170724-201709180824-R31","unstructured":"Global Polio Eradication Initiative. Polio pipeline No. 8\u2014summer 2011 [cited 2017 Apr 8]. http:\/\/polioeradication.org\/tools-and-library\/research-innovation\/polio-pipeline\/polio-pipeline-no-8-summer-2011\/"},{"key":"key-10.3201\/eid2310.170724-201709180824-R32","first-page":"641","article-title":"Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis.","volume":"46","author":"Centers for Disease Control and Prevention (CDC)","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2310.170724-201709180824-R33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients.","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/23\/10\/17-0724_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:29:06Z","timestamp":1732922946000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/23\/10\/17-0724_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2310.170724","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}